Corrigendum to "Cardiovascular safety of genetically proxied interleukin-5 inhibition: A mendelian randomization study" [Respir Invest 61 (2023) 149-152]

Respir Investig. 2024 Jan;62(1):142. doi: 10.1016/j.resinv.2023.12.002. Epub 2023 Dec 19.

Authors

Philip Alton¹, David M Hughes², Sizheng Steven Zhao³

Affiliations

¹ Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
² Department of Health Data Science, University of Liverpool, Liverpool, UK.
³ Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: [email protected].

PMID: 38118292
DOI: 10.1016/j.resinv.2023.12.002

No abstract available

Publication types

Published Erratum